XML 106 R36.htm IDEA: XBRL DOCUMENT
v3.23.2

Share-Based Compensation (Tables) | 6 Months Ended
--- | ---
Jul. 01, 2023
Share-Based Payment Arrangement [Abstract] |
Schedule of Compensation Expense and Related Income Tax benefit | The compensation expense from the Company’s share-based compensation plans and associated income tax benefit, excluding the effects of excess tax benefits or shortfalls, were included in the Consolidated Statements of Operations as follows (in millions):
| Three Months Ended |  | Six Months Ended
Compensation costs and related income tax benefit | July 1, 2023 |  | July 2, 2022 |  | July 1, 2023 |  | July 2, 2022
Cost of sales | $ | 2 |  |  | $ | 1 |  |  | $ | 3 |  |  | $ | 2 |
Selling and marketing | 1 |  |  | 6 |  |  | 7 |  |  | 10 |
Research and development | 6 |  |  | 10 |  |  | 13 |  |  | 16 |
General and administration | (6) |  |  | 10 |  |  | 3 |  |  | 16 |
Total compensation expense | $ | 3 |  |  | $ | 27 |  |  | $ | 26 |  |  | $ | 44 |
Income tax benefit | $ | 3 |  |  | $ | 5 |  |  | $ | 7 |  |  | $ | 8 |
Schedule of Restricted and Performance Stock-settled Awards | A summary of the Company’s restricted and performance stock-settled awards for the six months ended July 1, 2023 is as follows:
| RSUs |  | PSUs |  | RSAs |  |  | PSAs
| Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  | Weighted-Average Grant Date Fair Value
Outstanding at beginning of period | 242,732 |  |  | $ | 404.19 |  |  | 105,928 |  |  | $ | 406.89 |  |  | 46,971 |  |  | $ | 271.92 |  |  |  | 35,246 |  |  | $ | 245.79 |
Granted | 279,224 |  |  | 265.58 |  |  | 104,446 |  |  | 258.63 |  |  | 6,640 |  |  | 271.77 |  |  |  | — |  |  | — |
Released | (74,829) |  |  | 403.10 |  |  | (64) |  |  | 482.42 |  |  | (45,129) |  |  | 252.61 |  |  |  | (34,525) |  |  | 244.97 |
Forfeited | (11,198) |  |  | 425.27 |  |  | (1,096) |  |  | 389.82 |  |  | (1,375) |  |  | 300.62 |  |  |  | (75) |  |  | 244.97 |
Outstanding at end of period | 435,929 |  |  | $ | 314.40 |  |  | 209,214 |  |  | $ | 332.94 |  |  | 7,107 |  |  | $ | 384.26 |  |  |  | 646 |  |  | $ | 291.43 |
Schedule of SARs Activity | A summary of the Company’s SARs for the six months ended July 1, 2023 is as follows:
|  | SARs |  | Weighted-Average Exercise Price
Outstanding at beginning of period |  | 443,476 |  |  | $ | 122.67 |
Granted |  | — |  |  | — |
Exercised |  | (24,576) |  |  | 98.86 |
Forfeited |  | (157) |  |  | 239.89 |
Expired |  | — |  |  | — |
Outstanding at end of period |  | 418,743 |  |  | $ | 124.02 |
Exercisable at end of period |  | 403,092 |  |  | $ | 118.58 |
Schedule of SARs Outstanding | The following table summarizes information about SARs outstanding as of July 1, 2023:
| Outstanding |  | Exercisable
Aggregate intrinsic value (in millions) | $ | 72 |  |  | $ | 72 |
Weighted-average remaining contractual life (in years) | 2.2 |  | 2.1

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration